GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Shiller PE Ratio

Heron Therapeutics (STU:AXD2) Shiller PE Ratio : (As of Jun. 08, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Heron Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Heron Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Shiller PE Ratio Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Heron Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Heron Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Heron Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heron Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Shiller PE Ratio falls into.



Heron Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Heron Therapeutics's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Heron Therapeutics's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.018/131.7762*131.7762
=-0.018

Current CPI (Mar. 2024) = 131.7762.

Heron Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.574 100.560 -0.752
201409 -0.512 100.428 -0.672
201412 -0.576 99.070 -0.766
201503 -0.647 99.621 -0.856
201506 -0.659 100.684 -0.863
201509 -0.561 100.392 -0.736
201512 -0.799 99.792 -1.055
201603 -0.826 100.470 -1.083
201606 -1.041 101.688 -1.349
201609 -1.105 101.861 -1.430
201612 -1.157 101.863 -1.497
201703 -0.935 102.862 -1.198
201706 -0.712 103.349 -0.908
201709 -0.646 104.136 -0.817
201712 -0.929 104.011 -1.177
201803 -0.657 105.290 -0.822
201806 -0.462 106.317 -0.573
201809 -0.420 106.507 -0.520
201812 -0.554 105.998 -0.689
201903 -0.708 107.251 -0.870
201906 -0.558 108.070 -0.680
201909 -0.381 108.329 -0.463
201912 -0.585 108.420 -0.711
202003 -0.516 108.902 -0.624
202006 -0.542 108.767 -0.657
202009 -0.543 109.815 -0.652
202012 -0.559 109.897 -0.670
202103 -0.487 111.754 -0.574
202106 -0.515 114.631 -0.592
202109 -0.434 115.734 -0.494
202112 -0.478 117.630 -0.535
202203 -0.572 121.301 -0.621
202206 -0.520 125.017 -0.548
202209 -0.384 125.227 -0.404
202212 -0.160 125.222 -0.168
202303 -0.252 127.348 -0.261
202306 -0.323 128.729 -0.331
202309 -0.159 129.860 -0.161
202312 -0.046 129.419 -0.047
202403 -0.018 131.776 -0.018

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Heron Therapeutics  (STU:AXD2) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Heron Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Heron Therapeutics (STU:AXD2) Business Description

Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (STU:AXD2) Headlines

No Headlines